Head and Neck Tumors
Showing 1 - 25 of >10,000
Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- Solid Tumors
- Head and Neck Cancer
- SYH2051 tablets
- Intensity-Modulated Radiation Therapy (IMRT)
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 21, 2023
Head and Neck Squamous Cell Carcinoma Trial (HS-20093)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- (no location specified)
Aug 17, 2023
Head and Neck Tumors Trial (intraoperative navigation and creation of tumor resection maps)
Not yet recruiting
- Head and Neck Tumors
- intraoperative navigation and creation of tumor resection maps
- (no location specified)
Jan 2, 2023
Head and Neck Tumors Trial in Nanjing (Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU)
Recruiting
- Head and Neck Tumors
- Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
-
Nanjing, Jiangsu, ChinaDepartment of Oncology, Drum Tower Hospital, Nanjing University
Feb 24, 2023
Early Postoperative Mobilization in Recovery of Oral Head and
Completed
- Length of Hospital Stay
- Early Mobilization
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital
May 1, 2023
Objective Response Rate Trial in Wuhan (GM-CSF)
Recruiting
- Objective Response Rate
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 25, 2023
Head and Neck Tumors, Malignant Tumor of Vertebral Column Trial in Boston (Cryoablation, Biopsy)
Completed
- Head and Neck Neoplasms
- Malignant Neoplasm of Vertebral Column
- Cryoablation
- Biopsy
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Head and Neck Tumors Trial in Ghent (GRID radiotherapy)
Terminated
- Head and Neck Tumors
- GRID radiotherapy
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)
Not yet recruiting
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- disitamab vedotin
- (no location specified)
Aug 15, 2023
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Tumors of Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
Active, not recruiting
- Radiation Therapy Complication
- +2 more
- Spatially Fractionated Radiation (GRID) Therapy
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 31, 2022
Malignant Tumor in the Head and Neck, Metastatic Malignant Tumor in the Head and Neck Trial in Seattle (other, procedure, drug)
Not yet recruiting
- Malignant Neoplasm in the Head and Neck
- Metastatic Malignant Neoplasm in the Head and Neck
- Iodixanol
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2022
3D-PCT Combined With CT-guided Radioactive I-125 Seed
Recruiting
- Malignant Tumor of Head and/or Neck
- Radioactive Iodine-125 Seeds Implantation
-
Beijing, ChinaDepartment of Radiation Oncology of Peking university third hosp
Jul 18, 2022
Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)
Recruiting
- Lung Cancer Squamous Cell
- +3 more
-
Boston, Massachusetts
- +2 more
Jan 9, 2023
Head and Neck Cancer in Children: A Retrospective Study
Recruiting
- Head and Neck Neoplasms
- +4 more
-
Assiut, EgyptAssiut University
Apr 11, 2022
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Experimental: Stage 1L: HLX10 Plus HLX07, Experimental: Stage 1H: HLX10
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Experimental: Stage 1L: HLX10 Plus HLX07
- Experimental: Stage 1H: HLX10 Plus HLX07
-
Shanghai, Shanghai, ChinaShanghai Henlius Biotech Inc.
May 5, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in San Antonio (SRF114)
Recruiting
- Advanced Solid Tumor
- Head and Neck Squamous Cell Carcinoma
-
San Antonio, TexasSTART- San Antonio
Jan 2, 2023
Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)
Recruiting
- Unknown Primary Tumors
- Oropharynx Cancer
- Detection of lesions using fluorescence molecular imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Oct 20, 2023
Molecular and Genomic Profiling of Head and Neck Tumors
Recruiting
- Head and Neck Neoplasms
-
Bronx, New YorkStelby Augustine
Feb 17, 2022
Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous
Active, not recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- +3 more
- 200 mg Pembrolizumab
- +2 more
-
Miami, Florida
- +6 more
Jan 9, 2023
Head Neck Cancer Trial in Guangzhou (Jeksung combined with anti-radiation spray)
Recruiting
- Head and Neck Cancer
- Jeksung combined with anti-radiation spray
-
Guangzhou, Guangdong, ChinaYu Zeng
May 4, 2022